Estimation of the presence of cardiovascular events and direct costs associated with chronic obstructive pulmonary disease in an ambulatory setting

被引：1

作者：

Sicras Mainar, Antoni ^{[1
]}

Navarro Artieda, Ruth

de Bobadilla, Jaime Fernandez

Garcia Vargas, Mercedes

机构：

[1] Badalona Serv Assistencials, Direcc Planificac, Barcelona, Spain

[2] Hosp Badalona Germans Trias & Pujol, Serv Documentac, Barcelona, Spain

[3] Pfizer SA, Unidad Med, Hlth Outcomes Res, Madrid, Spain

来源：

MEDICINA CLINICA | 2007年 / 128卷 / 08期

关键词：

D O I：

10.1016/S0025-7753(07)72573-3

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：317 / 318

页数：2

共 10 条

[1]

Alonso JLI, 2005, ARCH BRONCONEUMOL, V41, P410

[2]

Arroyo-Espliguero R, 2004, REV ESP CARDIOL, V57, P375

[3]

Díaz JIJ, 2003, ARCH BRONCONEUMOL, V39, P554

[4]

IZQUIERDO JL, 2004, J COPD, V1, P215

[5]

Miravitlles M, 2005, Rev Clin Esp, V205, P439, DOI 10.1157/13079073

[6] Costs of chronic bronchitis and COPD - A 1-year follow-up study [J].

Miravitlles, M ;

Murio, C ;

Guerrero, T ;

Gisbert, R .

CHEST, 2003, 123 (03) :784-791

[7] Evidence based medicine: What it is and what it isn't - It's about integrating individual clinical expertise and the best external evidence [J].

Sackett, DL ;

Rosenberg, WMC ;

Gray, JAM ;

Haynes, RB ;

Richardson, WS .

BRITISH MEDICAL JOURNAL, 1996, 312 (7023) :71-72

[8] Chronic obstructive pulmonary disease: a novel risk factor for cardiovascular disease [J].

Sin, DD ;

Man, SFP .

CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2005, 83 (01) :8-13

[9] Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease [J].

Sin, DD ;

Man, SFP .

CIRCULATION, 2003, 107 (11) :1514-1519

[10] Survival in COPD patients after regular use of fluticasone propionate and salmeterol [J].

Soriano, JB ;

Vestbo, J ;

Pride, NB .

EUROPEAN RESPIRATORY JOURNAL, 2003, 21 (03) :560-560

← 1 →